Abstract
A lack of entrepreneurial behaviour has often been highlighted as a contributor to the decline in the research and development (R&D) productivity of the pharmaceutical industry. Here, we present an assessment of entrepreneurship in the industry, based on interviews with 26 former and current leaders of R&D departments at major pharmaceutical and biotechnology companies. Factors are highlighted that could be important in promoting entrepreneurial behaviour, which might serve as a catalyst for revitalizing R&D productivity. © 2010 Macmillan Publishers Limited. All rights reserved.
Cite
CITATION STYLE
Douglas, F. L., Narayanan, V. K., Mitchell, L., & Litan, R. E. (2010, September). The case for entrepreneurship in R&D in the pharmaceutical industry. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd3230
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.